Your shopping cart is currently empty

HIV-1inhibitor-66 is an orally active non-nucleoside reverse transcriptase inhibitor (NNRTI) that exhibits inhibitory activity against wild-type HIV-1 reverse transcriptase (HIV-1 reverse transcriptase) with an IC50 of 40 nM.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | HIV-1inhibitor-66 is an orally active non-nucleoside reverse transcriptase inhibitor (NNRTI) that exhibits inhibitory activity against wild-type HIV-1 reverse transcriptase (HIV-1 reverse transcriptase) with an IC50 of 40 nM. |
| In vitro | HIV-1 inhibitor-66 (compound 10n) effectively inhibits wild-type (WT) HIV-1 (IIIB) and NNRTI-resistant strains. The EC 50 values for HIV-1 IIIB, L100I, K103N, Y181C, Y188L, E138K, F227L/V106A, and RES056 (K103N/Y181C) are 0.009 μM, 0.011 μM, 0.013 μM, 0.018 μM, 0.703 μM, 0.013 μM, 17.7 μM, and 0.059 μM, respectively. |
| In vivo | HIV-1 inhibitor-66 (compound 10n) exhibits excellent pharmacokinetic properties in rats, characterized by a half-life (T 1/2) of 5.09 hours and a bioavailability (F) of 108.96%. It has been verified to have no acute or subacute toxicity in vivo, with an LD50 greater than 2000 mg/kg. |
| Formula | C22H15BrClF3N4O3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.